Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus. Local targets link to admitted publications; unresolved targets remain external evidence.
10.2337/diacare.21.4.518
10.2337/diacare.21.4.518 · External reference
Diabetes in America: epidemiology and scope of the problem
10.2337/diacare.21.3.c11 · 1998 · External reference
10.2337/diacare.20.11.1744
10.2337/diacare.20.11.1744 · External reference
Weight control: metabolic and cardiovascular effects
1995 · External reference
10.1001/archinte.1987.00370100063012
10.1001/archinte.1987.00370100063012 · External reference
10.2337/diacare.17.5.490
10.2337/diacare.17.5.490 · External reference
10.2337/diacare.21.3.350
10.2337/diacare.21.3.350 · External reference
10.1111/j.1464-5491.1992.tb01756.x
10.1111/j.1464-5491.1992.tb01756.x · External reference
10.1111/j.1464-5491.1995.tb00504.x
10.1111/j.1464-5491.1995.tb00504.x · External reference
Effects in the rat of sibutramine on food intake and the behavioural satiety sequence [abstract]
1994 · External reference
10.1016/0028-3908(89)90048-8
10.1016/0028-3908(89)90048-8 · External reference
Sibutramine: a novel anti‐obesity drug. A review of the pharmacological evidence to differentiate it from d‐amphetamine and d‐fenfluramine
1998 · External reference
10.1007/bf02244604
10.1007/bf02244604 · External reference
Sibutramine enhances weight loss and improves glycemic control and plasma lipid profile in obese patients with type 2 diabetes mellitus [abstract]
1999 · External reference
10.1016/s0002-9343(98)00411-2
10.1016/s0002-9343(98)00411-2 · External reference
10.1038/sj.ijo.0800540
10.1038/sj.ijo.0800540 · External reference
10.1002/j.1550-8528.1999.tb00701.x
10.1002/j.1550-8528.1999.tb00701.x · External reference
10.2337/diab.28.12.1039
10.2337/diab.28.12.1039 · External reference
10.1097/00005650-199206000-00002
10.1097/00005650-199206000-00002 · External reference
10.1002/j.1550-8528.1995.tb00120.x
10.1002/j.1550-8528.1995.tb00120.x · External reference
10.1093/biomet/52.3-4.591
10.1093/biomet/52.3-4.591 · External reference
Unresolved reference
1960 · External reference
10.2307/1402373
10.2307/1402373 · External reference
10.2337/diacare.18.6.896
10.2337/diacare.18.6.896 · External reference
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report
1998 · External reference
10.7326/0003-4819-79-3-425
10.7326/0003-4819-79-3-425 · External reference
10.1016/0002-9149(94)90676-9
10.1016/0002-9149(94)90676-9 · External reference
10.2165/00003495-199856060-00019
10.2165/00003495-199856060-00019 · External reference
10.2337/diab.35.2.155
10.2337/diab.35.2.155 · External reference
10.1001/archinte.148.4.873
10.1001/archinte.148.4.873 · External reference
10.2337/diacare.10.5.563
10.2337/diacare.10.5.563 · External reference
10.2337/diacare.21.8.1288
10.2337/diacare.21.8.1288 · External reference
10.1016/0026-0495(90)90299-r
10.1016/0026-0495(90)90299-r · External reference
Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey
10.1001/jama.1989.03430030048032 · 1989 · External reference
10.1007/bf00265546
10.1007/bf00265546 · External reference
10.2337/diab.30.2.s82
10.2337/diab.30.2.s82 · External reference
Relation of glycemic control to diabetic complications and health outcomes
10.2337/diacare.21.3.c39 · 1998 · External reference
10.1001/jama.281.3.235
10.1001/jama.281.3.235 · External reference
10.1016/s0140-6736(97)11509-4
10.1016/s0140-6736(97)11509-4 · External reference
A single‐dose, placebo‐controlled, comparative evaluation of the cardiovascular effects of sibutramine and amitriptyline in normal volunteers
1997 · External reference
Fluoxetine in obese patients with noninsulin‐dependent diabetes mellitus [abstract]
1992 · External reference
Fluoxetine treatment of the obese diabetic
1992 · External reference
Sibutramine in the treatment of overweight non‐insulin dependent diabetics [abstract O72]
1998 · External reference
Body composition changes following weight loss induced by sibutramine [abstract P395]
1995 · External reference
Sibutramine reduces visceral fat, leptin, and estradiol level in obese women
1998 · External reference
10.2337/diacare.11.2.103
10.2337/diacare.11.2.103 · External reference
